At a glance
ClinicalIndex Comparison RecordN/ACompleted· 203 enrolled
Drug / intervention
ReActiv8device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation
In Brief
A clinical study evaluating ReActiv8 for Chronic Low-back Pain. Completed, enrolled 203 participants across 28 sites.
Detailed Summary
This study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Low-back Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartJul 2021
Primary CompletionSep 2024
Study CompletionJan 2026
TodayJul 2026
First PostedMar 17, 2021
Enrollment StartJul 14, 2021
Primary CompletionSep 4, 2024
Study CompletionJan 5, 2026
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 5.3 years ago
Interventions
ReActiv8device
Market-approved ReActiv8 device implanted